This screen shot shows France’s President Emmanuel Macron speaking during a televised address to the nation during which he Read More
Apple announces its AI push, Apple Intelligence. Apple announced its long-awaited artificial intelligence push, Apple Intelligence. CEO Tim Cook emphasized Read More
Investors maintained their bullish stance on stocks for the seventh consecutive week, pouring $4.6 billion into U.S. equity funds. U.Read More
Fool.com contributor Parkev Tatevosian discusses an important factor to remember when considering the Nvidia (NASDAQ: NVDA) stock split.Read More
If you have outstanding student loans, you’re probably wondering what November’s election will bring. Will your student loans Read More
Huntington Bancshares (NASDAQ: HBAN) stock fell 5.3% through 10 a.m. ET on Monday after the company’s CFO let slip some Read More
Artificial intelligence (AI) has captivated the tech world over the last year, with many companies pivoting their businesses toward the Read More
The police use water cannon against climate activists of “Extinction Rebellion” movement, who block the Utrechtsebaan on the A12 road, Read More
June S&P 500 E-Mini futures (ESM24) are down -0.09%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.04% this Read More
Nvidia (NASDAQ: NVDA) shares soon will trade at about a 10th of last week’s price — and for good reason. Read More
Are you on the hunt for hot tech stocks? Are you bullish about cloud computing and artificial intelligence? That’s Read More
Since its late July 2021 IPO, Robinhood Markets (NASDAQ:HOOD) stock has seen a tumultuous journey, yet its stock soared 137% over Read More
European Commission Approves Roche’s Alecensa For ALK-positive
(RTTNews) – Roche (RHHBY) said that the European Commission has approved Alecensa (alectinib) monotherapy, as adjuvant treatment following tumour resection for Read More
(RTTNews) – European stocks are seen opening on a sluggish note Monday as a snap election call in France sparked wider Read More
(RTTNews) – Roche (RHHBY) said that the U.S. Food and Drug Administration has granted Emergency Use Authorization for its cobas Read More
Eli Lilly stock (NYSE: LLY) has seen phenomenal gains of 400% from levels of $170 in early 2021 to around $840 now. This reflects Read More
An employee enters sliding doors decorated with the stars of the European Union (EU) flag at the Berlaymont building, headquarters Read More